Get startedLog in
    Picture of Recordati Industria Chimica E Farmaceutica SpA logo

    REC — Recordati Industria Chimica E Farmaceutica SpA News Story

    0.000.00%
    it flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Recordati FY EBITDA EUR 991.1 Mln

    Picture of Recordati Industria Chimica E Farmaceutica SpA logoRecordati Industria Chimica E Farmaceutica SpA
    17/02/2026 16:54
    Feb 17 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI:

FY EBITDA EUR 991.1 MILLION

FY ADJUSTED NET PROFIT EUR 651.1 MILLION

FY REVENUE EUR 2.62 BILLION

TARGETS 2026 NET REVENUES OF €2.73-2.80 BILLION

SEES IN 2026 EBITDA IN RANGE OF EUR 995 MILLION-EUR 1.03 BILLION

SEES IN 2026 ADJUSTED NET PROFIT IN RANGE OF EUR 655-685 MILLION

TARGETS FOR FISCAL YEAR 2027 REMAIN UNCHANGED

SEES FOR 2027 STRONG ORGANIC GROWTH, TARGETED BUSINESS DEVELOPMENT OPERATIONS, M&A ACTIVITIES

Further company coverage: RECI.MI

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Recordati Industria Chimica E Farmaceutica SpA

    See all news